4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-067613
President and CEO acquired 1,118 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph President and CEO | 2021-11-30 | Option exercise | +1,118 | $4.47 | $4,997 | 2,685 | D |
| Derivatives | |||||||
| OConnell Daniel Joseph President and CEO | 2021-11-30 | Option exercise · Stock Option (Right to Buy) | −1,118 | 0 | D | ||
Loading xslF345X03/doc4.xml…